Intestinal helminth co-infection is an unrecognised risk factor for increased pneumococcal carriage density and invasive disease.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
26 03 2021
Historique:
received: 03 09 2020
accepted: 08 02 2021
entrez: 27 3 2021
pubmed: 28 3 2021
medline: 16 10 2021
Statut: epublish

Résumé

Infection with Streptococcus pneumoniae is the leading cause of death in children and burden of disease is greatest where helminth infections are also common. We investigated the impact of intestinal helminth co-infection on pneumococcal carriage; a risk factor for invasive disease. We used a mouse co-infection model and clinical data to assess the impact of co-infection on carriage density. Co-infection in mice was associated with increased pneumococcal carriage density and dissemination into lungs. Helminth-infected children also exhibited increased carriage density as compared to uninfected children. Anthelmintic treatment may be a cost-effective method of reducing pneumococcal disease burden in lower-income countries.

Identifiants

pubmed: 33772094
doi: 10.1038/s41598-021-86508-4
pii: 10.1038/s41598-021-86508-4
pmc: PMC7997997
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

6984

Subventions

Organisme : Wellcome Trust
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 204457/Z/16/Z
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/P011284/1
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 088862/Z/09/Z
Pays : United Kingdom

Références

Lancet Infect Dis. 2004 Mar;4(3):144-54
pubmed: 14998500
PLoS One. 2015 Oct 14;10(10):e0140112
pubmed: 26466142
Lancet Infect Dis. 2018 Nov;18(11):1191-1210
pubmed: 30243584
Pediatr Infect Dis J. 2011 Jun;30(6):480-5
pubmed: 21593705
Lancet Infect Dis. 2014 Nov;14(11):1150-1162
pubmed: 24981042
J Clin Microbiol. 2007 Aug;45(8):2460-6
pubmed: 17537936
Am J Respir Crit Care Med. 2014 May 15;189(10):1250-9
pubmed: 24749506
J Infect. 2011 Sep;63(3):200-6
pubmed: 21704071
J Allergy Clin Immunol. 2017 Mar;139(3):977-986.e2
pubmed: 27523432
J Allergy Clin Immunol. 2020 Apr;145(4):1272-1284.e6
pubmed: 31983527
Clin Infect Dis. 2012 Mar 1;54(5):601-9
pubmed: 22156852
Nat Immunol. 2013 Nov;14(11):1118-1126
pubmed: 24145791
Parasit Vectors. 2019 Aug 14;12(1):402
pubmed: 31412915
Parasitology. 1967 Aug;57(3):515-24
pubmed: 6048569
Lancet. 2009 Sep 12;374(9693):893-902
pubmed: 19748398
Parasit Vectors. 2014 Jan 21;7:37
pubmed: 24447578
Sci Rep. 2018 Mar 14;8(1):4508
pubmed: 29540816
Immunol Rev. 2014 Jul;260(1):183-205
pubmed: 24942690
Immunobiology. 2010 Apr;215(4):251-63
pubmed: 20071053
Int J Epidemiol. 2015 Oct;44(5):1517-27
pubmed: 24990475
PLoS Negl Trop Dis. 2014 Feb 27;8(2):e2718
pubmed: 24587469
Clin Microbiol Infect. 2014 Dec;20(12):O1145-51
pubmed: 24995531

Auteurs

Alice E Law (AE)

Department of Clinical Immunology, Microbiology and Immunology, Institute of Infection, Veterinary and Ecological Sciences, University of Liverpool, Liverpool, UK.

Rebecca K Shears (RK)

Department of Clinical Immunology, Microbiology and Immunology, Institute of Infection, Veterinary and Ecological Sciences, University of Liverpool, Liverpool, UK.

Andrea A Lopez Rodas (AA)

School of Medicine, Universidad Internacional del Ecuador, Quito, Ecuador.

Richard K Grencis (RK)

School of Biological Sciences, Lydia Becker Institute of Immunology and Inflammation, Wellcome Centre for Cell Matrix Research, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre, University of Manchester, Manchester, UK.

Philip J Cooper (PJ)

School of Medicine, Universidad Internacional del Ecuador, Quito, Ecuador.
Institute of Infection and Immunity, St George's University of London, London, UK.

Daniel R Neill (DR)

Department of Clinical Immunology, Microbiology and Immunology, Institute of Infection, Veterinary and Ecological Sciences, University of Liverpool, Liverpool, UK.

Aras Kadioglu (A)

Department of Clinical Immunology, Microbiology and Immunology, Institute of Infection, Veterinary and Ecological Sciences, University of Liverpool, Liverpool, UK. a.kadioglu@liverpool.ac.uk.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH